Referenties

Alifano M, D'Aiuto M, Magdeleinat P, Poupardin E, Chafik A, Strano S, et al. Surgical treatment of superior sulcus tumors: results and prognostic factors. Chest 2003;124(3), 996-1003#http://www.ncbi.nlm.nih.gov/pubmed/12970029

Andersson BA. Gemcitabine treatment in pancreatic cancer - Prognostic factors and outcome. Annals of Gastroenterology 2007;20(2) Ando MA. Prognostic factors for short-term survival in patients with stage IV non-small cell lung cancer. Japanese Journal of Cancer Research 1999;90(2), 249-253#http://www.ncbi.nlm.nih.gov/pubmed/10189897

Andreyev HJ, Norman AR, Oates J, Cunningham D, Andreyev HJ, Norman AR, et al.Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? European Journal of Cancer 34(4), 503-509, 1998#http://www.ncbi.nlm.nih.gov/pubmed/9713300

Argiris AL. Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck: An analysis of two Eastern Cooperative Oncology Group randomized trials. Cancer 2004;101(10), 2222-2229#http://www.ncbi.nlm.nih.gov/pubmed/15452834

Aviles A, Yanez J, Lopez T, Garcia EL, Guzman R, Diaz-Maqueo JC, et al. Malnutrition as an adverse prognostic factor in patients with diffuse large cell lymphoma. Archives of Medical Research 1995;26(1), 31-34#http://www.ncbi.nlm.nih.gov/pubmed/7711444

Bachmann J, Heiligensetzer M, Krakowski-Roosen H, Buchler MW, Friess H, Martignoni ME, et al. Cachexia worsens prognosis in patients with resectable pancreatic cancer. Journal of Gastrointestinal Surgery 2008;12(7), 1193-1201#http://www.ncbi.nlm.nih.gov/pubmed/18347879

Bakaeen FG, Murr MM, Sarr MG, Thompson GB, Farnell MB, Nagorney DM, et al. What prognostic factors are important in duodenal adenocarcinoma? Archives of Surgery 2000;135(6), 635-641.#http://www.ncbi.nlm.nih.gov/pubmed/10843358

Bettini R, Boninsegna L, Mantovani W, Capelli P, Bassi C, Pederzoli P, et al.Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours. Annals of Oncology 2008, 19(5), 903-908.#http://www.ncbi.nlm.nih.gov/pubmed/18209014

Bokhorst van-de van der Schuer, van Leeuwen PA, Kuik DJ, Klop WM, Sauerwein HP, Snow GB, Quak JJ. The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer 1999;86(3):519-27.#http://www.ncbi.nlm.nih.gov/pubmed/10430262

Borasio P, Berruti A, Bille A, Lausi P, Levra MG, Giardino R, et al. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients. Eur J Cardiothorac Surg 2008 Feb;33(2):307-13 Bremnes RM, Sundstrom S, Aasebo U, Kaasa S, Hatlevoll R, Aamdal S, et al. The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up. Lung Cancer 2003;39(3),303-313.#http://www.ncbi.nlm.nih.gov/pubmed/12609569

Buccheri G, Ferrigno D. Importance of weight loss definition in the prognostic evaluation of non-small-cell lung cancer. Lung Cancer 2001;34(3): 433-440.#http://www.ncbi.nlm.nih.gov/pubmed/11714541

Buccheri GF, Ferrigno D, Tamburini M, Brunelli C et al.The patient's perception of his own quality of life might have an adjunctive prognostic significance in lung cancer. Lung Cancer 12(1-2), 45-58, 1995.#http://www.ncbi.nlm.nih.gov/pubmed/7600030

Capuano G, Grosso A, Gentile PC, Battista M, Bianciardi F, Di PA, et al. Influence of weight loss on outcomes in patients with head and neck cancer undergoing concomitant chemoradiotherapy. Head & Neck 2008;30(4): 503-508.#http://www.ncbi.nlm.nih.gov/pubmed/18098310

Casas F, Vinolas N, Ferrer F, Farrus B, Gimferrer JM, Agusti C, et al. Improvement in performance status after erythropoietin treatment in lung cancer patients undergoing concurrent chemoradiotherapy. International Journal of Radiation Oncology, Biology, Physics 2003;55(1):116-124.#http://www.ncbi.nlm.nih.gov/pubmed/12504043

Christein JD, Hollinger EF, Millikan KW, Christein JD, Hollinger EF, Millikan KW. Prognostic factors associated with resectable carcinoma of the esophagus. American urgeon 2002;68(3):258-262.#http://www.ncbi.nlm.nih.gov/pubmed/11893104

Christodolou C, Pavlidis N, Samantas E, Fountzilas G, Kouvatseas G, et al. Prognostic factors in Greek patients with small cell lung cancer (SCLC). A Hellenic Cooperative Oncology Group study. Anticancer Res 2002;22(6B):3749-57.#http://www.ncbi.nlm.nih.gov/pubmed/12552988

Colinet B, Jacot W, Bertrand D, Lacombe S, Bozonnat MC, Daures JP, et al. A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index. British Journal of Cancer 2005;93(10):1098-1105.#http://www.ncbi.nlm.nih.gov/pubmed/16234816

Conlon KC, Casper ES, Brennan MF, Conlon KC, Casper ES, Brennan MF. Primary gastrointestinal sarcomas: analysis of prognostic variables. Annals of Surgical Oncology 1995;2(1):26-31. Cos de JS, Miravet L, Abal J, Nunez A, Munoz FJ, Garcia L, et al. Lung cancer survival in Spain and prognostic factors: a prospective, multiregional study. Lung Cancer 2008;59(2):246-254.#http://www.ncbi.nlm.nih.gov/pubmed/17889402

Costa ML, de Cassia Braga RK, Machado MA, Costa AC, Montagnini AL, Costa MLV, et al. Prognostic score in gastric cancer: the importance of a conjoint analysis of clinical, pathologic, and therapeutic factors. Annals of Surgical Oncology 2006;13(6):843-850.#http://www.ncbi.nlm.nih.gov/pubmed/16614885

Deans DA, Wigmore SJ, de Beaux AC, Paterson-Brown S, Garden OJ, Fearon KC. Clinical prognostic scoring system to aid decision-making in gastro-oesophageal cancer. Br J Surg 2007;94(12):1501-8.#http://www.ncbi.nlm.nih.gov/pubmed/17703501

Dequanter D, Lothaire P, Comblain M, Philippart J, De Wan J, Deraemacker R, Andry G. Pharyngolaryngectomy for advanced and recurrent cancer: prognostic factors and complications). Rev Laryngol Otol Rhinol (Bord) 2004;125(2):93-101.#http://www.ncbi.nlm.nih.gov/pubmed/15462168

Di FF, Lecleire S, Pop D, Rigal O, Hamidou H, Paillot B, et al. Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer. American Journal of Gastroenterology 2007;102(11):2557-2563.#http://www.ncbi.nlm.nih.gov/pubmed/17680847

Di FF, Lecleire S, Rigal O, Galais MP, Ben SE, David I, et al. Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma. World Journal of Gastroenterology 2006;12(26):4185-4190.#http://www.ncbi.nlm.nih.gov/pubmed/16830371

Di FF, Lecleire S, Pop D, Rigal O, Hamidou H, Paillot B, et al. Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer. American Journal of Gastroenterology 2007;102(11):2557-2563.#http://www.ncbi.nlm.nih.gov/pubmed/17680847

Diculescu M, Iacob R, Iacob S, Croitoru A, Becheanu G, Popeneciu V, et al. The importance of histopathological and clinical variables in predicting the evolution of colon cancer. Romanian Journal of Gastroenterology 2002;11(3):183-189.#http://www.ncbi.nlm.nih.gov/pubmed/12368937

Dimopoulos MA, Hamilos G, Zervas K, Symeonidis A, Kouvatseas G, Roussou P, et al. Survival and prognostic factors after initiation of treatment in Waldenstrom's macroglobulinemia. Annals of Oncology 2003;14(8):1299-1305.#http://www.ncbi.nlm.nih.gov/pubmed/12881396

Dubray B, Mosseri V, Brunin F, Jaulerry C, Poncet P, Rodriguez J, et al. Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study. Radiology 1996;201(2):553-558.#http://www.ncbi.nlm.nih.gov/pubmed/8888257

Edwards JG, Abrams KR, Leverment JN, Spyt TJ, Waller DA, O'Byrne KJ. Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems. Thorax 2000;55(9):731-5.#http://www.ncbi.nlm.nih.gov/pubmed/10950889

Espinosa E, Feliu J, Zamora P, Gonzalez BM, Sanchez JJ, Ordon eA, et al. Serum albumin and other prognostic factors related to response and survival in patients with advanced non-small cell lung cancer. Lung Cancer 1995;12(1-2):67-76.#http://www.ncbi.nlm.nih.gov/pubmed/7600032

Ferrigno DB. Prognosis and lung cancer: The contribution of plasma proteins. Oncology Reports 1995;2(4); 647-41.#http://www.ncbi.nlm.nih.gov/pubmed/21597791

Florescu MH. A clinical prognostic index for patients treated with erlotinib in National Cancer Institute of Canada clinical trials group study BR.21. Journal of Thoracic Oncology 2008;3(6):590-598.#http://www.ncbi.nlm.nih.gov/pubmed/18520796

Fossa SD, Kramar A, Droz JP. Prognostic factors and survival in patients with metastatic renal cell carcinoma treated with chemotherapy or interferon-alpha. European Journal of Cancer 1994;30A(9):1310-1314.#http://www.ncbi.nlm.nih.gov/pubmed/7999419

Gerhardt T, Milz S, Schepke M, Feldmann G, Wolff M, Sauerbruch T, et al. C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma. World Journal of Gastroenterology 2006;12(34):5495-5500.#http://www.ncbi.nlm.nih.gov/pubmed/17006987

Gianotti L, Braga M, Radaelli G, Mariani L, Vignali A, Di C, V, et al. Lack of improvement of prognostic performance of weight loss when combined with other parameters. Nutrition 1995;11(1):12-16.#http://www.ncbi.nlm.nih.gov/pubmed/7749237

Gobbi PG, Bettini R, Montecucco C, Cavanna L, Morandi S, Pieresca C, et al. Study of prognosis in Waldenstrom's macroglobulinemia: a proposal for a simple binary classification with clinical and investigational utility. Blood 83(10), 2939-2945, 1994.#http://www.ncbi.nlm.nih.gov/pubmed/8180389

Gough DB, Donohue JH, Schutt AJ, Gonchoroff N, Goellner JR, Wilson TO, et al.Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Annals of Surgery 219(2), 112-119, 1994.#http://www.ncbi.nlm.nih.gov/pubmed/8129481

Grossmann EM, Longo WE, Virgo KS, Johnson FE, Oprian CA, Henderson W, et al.Morbidity and mortality of gastrectomy for cancer in Department of Veterans Affairs Medical Center. Surgery 131(5), 484-490,2002.#http://www.ncbi.nlm.nih.gov/pubmed/12019399 G

upta D, Lammersfeld CA, Vashi PG, Burrows J, Lis CG, Grutsch JF, et al Prognostic significance of Subjective Global Assessment (SGA) in advanced colorectal cancer. European Journal of Clinical Nutrition 59(1), 35-40, 2005.#http://www.ncbi.nlm.nih.gov/pubmed/15252422

Gupta D, Lammersfeld CA, Vashi PG, Dahlk SL, Lis CG. Can subjective global assessment of nutritional status predict survival in ovarian cancer? J Ovarian Res. 2008;1(1):5.#http://www.ncbi.nlm.nih.gov/pubmed/19014661

Gupta D, Lis CG, Granick J, Grutsch JF, Vashi PG, Lammersfeld CA, et al Malnutrition was associated with poor quality of life in colorectal cancer: a retrospective analysis. Journal of Clinical Epidemiology 59(7)#http://www.ncbi.nlm.nih.gov/pubmed/16765273

Haferkamp A, Pritsch M, Bedke J, Wagener N, Pfitzenmaier J, Buse S, Hohenfellner M. The influence of body mass index on the long-term survival of patients with renal cell carcinoma after tumour nephrectomy. BJU Int. 2008 May;101(10):1243-6.#http://www.ncbi.nlm.nih.gov/pubmed/18261150

Herndon JE, Green MR, Chahinian AP, Corson JM, Suzuki Y, Vogelzang NJ. Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest. 1998;113(3):723-31.#http://www.ncbi.nlm.nih.gov/pubmed/9515850  

Herndon JE 2nd. Patient education level as a predictor of survival in lung cancer clinical trials. Journal of Clinical Oncology 26(25), 4116-4123, 2008.#http://www.ncbi.nlm.nih.gov/pubmed/18757325

Hespanhol V, Queiroga H, Magalhaes A, Santos AR, Coelho M, Marques A, et al Survival predictors in advanced non-small cell lung cancer. Lung Cancer 13(3), 253-267, 1995.#http://www.ncbi.nlm.nih.gov/pubmed/8719065

Hess LM, Barakat R, Tian C, Ozols RF, Alberts DS, Hess LM, et al Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: a Gynecologic Oncology Group study.Gynecologic Oncology 107(2), 260-265, 2007.#http://www.ncbi.nlm.nih.gov/pubmed/17675142

Ikeda M, Natsugoe S, Ueno S, Baba M, Aikou T, Ikeda M, et al Significant host- and tumor-related factors for predicting prognosis in patients with esophageal carcinoma. Annals of Surgery 238(2), 197-202, 2003.#http://www.ncbi.nlm.nih.gov/pubmed/12894012

Jeremic B, Milicic B, Dagovic A, Aleksandrovic J, Nikolic N, Jeremic B, et al. Pretreatment clinical prognostic factors in patients with stage IV non-small cell lung cancer (NSCLC) treated with chemotherapy. Journal of Cancer Research & Clinical Oncology 129(2), 114-122, 2003.#http://www.ncbi.nlm.nih.gov/pubmed/12669236

Jeremic B, Milicic B, Dagovic A, Acimovic L, Milisavljevic S, Jeremic B, et al. Pretreatment prognostic factors in patients with early-stage (I/II) non-small-cell lung cancer treated with hyperfractionated radiation therapy alone. International Journal of Radiation Oncology, Biology, Physics 65(4), 1112-1119, 2006.#http://www.ncbi.nlm.nih.gov/pubmed/16682148

Jiao X, Krasna MJ, Sonett J, Gamliel Z, Suntharalingam M, Doyle A, et al. Pretreatment surgical lymph node staging predicts results of trimodality therapy in esophageal cancer. European Journal of Cardio-Thoracic Surgery 19(6), 880-886, 2001.#http://www.ncbi.nlm.nih.gov/pubmed/11404146

Julien S, Jacoulet P, Dubiez A, Westeel V, Depierre A, Julien S, et al. [Non-small-cell bronchial cancers: long-term survival after single drug chemotherapy with vinorelbine). Revue de Pneumologie Clinique 55(4), 205-210,1999.#http://www.ncbi.nlm.nih.gov/pubmed/10573748

Kama NA, Coskun T, Yuksek YN, Yazgan A, Kama NA, Coskun T, et al. Factors affecting post-operative mortality in malignant biliary tract obstruction. Hepato-Gastroenterology 46(25), 103-107, 1999.#http://www.ncbi.nlm.nih.gov/pubmed/10228772

Kastritis E, Bamias A, Bozas G, Koutsoukou V, Voulgaris Z, Vlahos G, et al. The impact of age in the outcome of patients with advanced or recurrent cervical cancer after platinum-based chemotherapy. Gynecologic Oncology 104(2), 372-376, 2007.#http://www.ncbi.nlm.nih.gov/pubmed/17030353 K

im HL, Belldegrun AS, Freitas DG, Bui MH, Han KR, Dorey FJ, et al. Paraneoplastic signs and symptoms of renal cell carcinoma: implications for prognosis.Journal of Urology 170(5), 1742-1746, 2003.#http://www.ncbi.nlm.nih.gov/pubmed/14532767

Kim HL, Han KR, Zisman A, Figlin RA, Belldegrun AS, Kim HL, et al. Cachexia-like symptoms predict a worse prognosis in localized t1 renal cell carcinoma. Journal of Urology 171(5), 1810-1813, 2004.#http://www.ncbi.nlm.nih.gov/pubmed/15076282

Kim RD, Kundhal PS, McGilvray ID, Cattral MS, Taylor B, Langer B, et al. Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma. Journal of the American College of Surgeons 202(1), 112-119, 2006.#http://www.ncbi.nlm.nih.gov/pubmed/16377504

Klatte T, Pantuck AJ, Riggs SB, Kleid MD, Shuch B, Zomorodian N, et al. Prognostic factors for renal cell carcinoma with tumor thrombus extension. Journal of Urology 178, 1189-1195, 2007.#http://www.ncbi.nlm.nih.gov/pubmed/17698087

Komaki R, Roth JA, Walsh GL, Putnam JB, Vaporciyan A, Lee JS, et al. Outcome predictors for 143 patients with superior sulcus tumors treated by multidisciplinary approach at the University of Texas M. D. Anderson Cancer Center. International Journal of Radiation Oncology, Biology, Physics 48(2), 347-354, 2000.#http://www.ncbi.nlm.nih.gov/pubmed/10974447

Kong FM, Ten Haken RK, Schipper MJ, Sullivan MA, Chen M, Lopez C, et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. International Journal of Radiation Oncology, Biology, Physics 63(2), 324-333, 2005.#http://www.ncbi.nlm.nih.gov/pubmed/16168827

Kramer H, Post WJ, Pruim J, Groen HJ, Kramer H, Post WJ, et al. The prognostic value of positron emission tomography in non-small cell lung cancer: analysis of 266 cases. Lung Cancer 52(2), 213-217, 2006.#http://www.ncbi.nlm.nih.gov/pubmed/16545488

Krishnan S, Rana V, Janjan NA, Abbruzzese JL, Gould MS, Das P, et al. Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation. Cancer 107(11), 2589-2596, 2006.#http://www.ncbi.nlm.nih.gov/pubmed/17083124

Kycler WT. Prognostic factors for patients with gastric cancer after surgical resection. Reports of Practical Oncology and Radiotherapy 11(5), 2006.# Langendijk H, Aaronson NK, de Jong JM, ten Velde GP, Muller MJ, Wouters M, et al. The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiotherapy & Oncology 55(1), 19-25, 2000.#http://www.ncbi.nlm.nih.gov/pubmed/10788684

Langley SM, Alexiou C, Bailey DH, Weeden DF, Langley SM, Alexiou C, et al. The influence of perioperative blood transfusion on survival after esophageal resection for carcinoma. Annals of Thoracic Surgery 73(6), 1704-1709, 2002.#http://www.ncbi.nlm.nih.gov/pubmed/12078756

Lehmann J, Suttmann H, Kovac I, Hack M, Kamradt J, Siemer S, et al. Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survival. European Urology 51(5), 1281-1288, 2007.#http://www.ncbi.nlm.nih.gov/pubmed/17125909

Lello E. Furnes. Short and long-term survival from gastric cancer. A population-based study from a county hospital during 25 years. Acta Oncologica 46(3), 308-315, 2007.#http://www.ncbi.nlm.nih.gov/pubmed/17450465

Liu S-AT. Nutritional factors and survival of patients with oral cancer. Head and Neck 28(11), 998-1007, 2006.#http://www.ncbi.nlm.nih.gov/pubmed/16906513 Lord RV, Brabender J, Gandara D, Alberola V, Camps C, Domine M, et al. Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. Clinical Cancer Research 8(7), 2286-2291, 2002.#http://www.ncbi.nlm.nih.gov/pubmed/12114432

Makela JT, Kiviniemi H, Wiik H, Laitinen S, Makela JT, Kiviniemi H, et al. Survival after surgery for gastric cancer in patients over 70 years of age. Annales Chirurgiae et Gynaecologiae 89(4), 268-272, 2000.#http://www.ncbi.nlm.nih.gov/pubmed/11204956

Maltoni M, Pirovano M, Scarpi E, Marinari M, Indelli M, Arnoldi E, et al. Prediction of survival of patients terminally ill with cancer. Results of an Italian prospective multicentric study. Cancer 75(10), 2613-2622, 1995.#http://www.ncbi.nlm.nih.gov/pubmed/7537625

Mani S, Todd MB, Katz K, Poo WJ, Mani S, Todd MB, et al. Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiers. Journal of Urology 154(1), 35-40, 1995.;#http://www.ncbi.nlm.nih.gov/pubmed/7539867 Maréchal R, Demols A, Gay F, De Maertelaere V, Arvanitaki M, Hendlisz A, Van Laethem JL. Prognostic factors and prognostic index for chemonaïve and gemcitabine-refractory patients with advanced pancreatic cancer. Oncology. 2007;73(1-2):41-51.#http://www.ncbi.nlm.nih.gov/pubmed/18334830

Martin-Ucar AE, Edwards JG, Rengajaran A, Muller S, Waller DA, Martin-Ucar AE, et al. Palliative surgical debulking in malignant mesothelioma. Predictors of survival and symptom control. European Journal of Cardio-Thoracic Surgery 20(6), 1117-1121, 2001.#http://www.ncbi.nlm.nih.gov/pubmed/11717014 M

artin-Ucar AE, Nicum R, Oey I, Edwards JG, Waller DA, Martin-Ucar AE, et al. En-bloc chest wall and lung resection for non-small cell lung cancer. Predictors of 60-day non-cancer related mortality. European Journal of Cardio-Thoracic Surgery 23(6), 859-864, 2003.#http://www.ncbi.nlm.nih.gov/pubmed/12829058

Martins SJ, Pereira JR, Martins SJ, Pereira JR. Clinical factors and prognosis in non-small cell lung cancer. American Journal of Clinical Oncology 22(5), 453-457,1999.#http://www.ncbi.nlm.nih.gov/pubmed/10521057

McKernan M, McMillan DC, Anderson JR, Angerson WJ, Stuart RC, McKernan M, et al. The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer. British Journal of Cancer 98(5), 888-893, 2008.#http://www.ncbi.nlm.nih.gov/pubmed/18268490

Michel P, Magois K, Robert V, Chiron A, Lepessot F, Bodenant C, et al. Prognostic value of TP53 transcriptional activity on p21 and bax in patients with esophageal squamous cell carcinomas treated by definitive chemoradiotherapy. International Journal of Radiation Oncology, Biology, Physics 54(2), 379-385, 2002#http://www.ncbi.nlm.nih.gov/pubmed/12243811

Mitry E, Douillard JY, Van Cutsem E, Cunningham D, Magherini E, Mery-Mignard D, Awad L, Rougier P. Predictive factors of survival in patients with advanced colorectal cancer: An indiviual data analysis of 602 patients included in irinotecan phase III trials. Ann Oncol. 2004 Jul;15(7):1013-7.#http://www.ncbi.nlm.nih.gov/pubmed/15205193

Navarro WH, Loberiza FR, Jr., Bajorunaite R, van BK, Vose JM, Lazarus HM, et al. Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation. Biology of Blood & Marrow Transplantation 12(5), 541-551, 2006.#http://www.ncbi.nlm.nih.gov/pubmed/16635789

Nguyen TV, Yueh B, Nguyen TV, Yueh B. Weight loss predicts mortality after recurrent oral cavity and oropharyngeal carcinomas. Cancer 95(3), 553-562, 2002.#http://www.ncbi.nlm.nih.gov/pubmed/12209747

Palomares MR, Sayre JW, Shekar KC, Lillington LM, Chlebowski RT, Palomares MR, et al. Gender influence on weight-loss pattern and survival of nonsmall cell lung carcinoma patients. Cancer 78(10), 2119-2126, 1996.#http://www.ncbi.nlm.nih.gov/pubmed/8918405

Papadoniou N, Kosmas C, Gennatas K, Polyzos A, Mouratidou D, Skopelitis E, et al. Prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis. Anticancer Research 28(1B), 543-549, 2008.#http://www.ncbi.nlm.nih.gov/pubmed/18383900

Pedruzzi PA, Kowalski LP, Nishimoto IN, Oliveira BV, Tironi F, Ramos GH, et al. Analysis of prognostic factors in patients with oropharyngeal squamous cell carcinoma treated with radiotherapy alone or in combination with systemic chemotherapy. Archives of Otolaryngology -- Head & Neck Surgery 134(11), 1196-1204. 2008.#http://www.ncbi.nlm.nih.gov/pubmed/19015451

Persson C, Glimelius B. The relevance of weight loss for survival and quality of life in patients with advanced gastrointestinal cancer treated with palliative chemotherapy. Anticancer Res. 2002 Nov-Dec;22(6B):3661-8.#http://www.ncbi.nlm.nih.gov/pubmed/12552973

Poole K, Froggatt K. Loss of weight and loss of appetite in advanced cancer: a problem for the patient, the carer or the health professional? Palliat Med 2002; 16: 499-506#http://www.ncbi.nlm.nih.gov/pubmed/12465697

Prat F, Chapat O, Ducot B, Ponchon T, Fritsch J, Choury AD, et al. Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline. Gut 42(1), 76-80, 1998#http://www.ncbi.nlm.nih.gov/pubmed/9505889

Ross PJ, Ashley S, Norton A, Priest K, Waters JS, Eisen T, et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? British Journal of Cancer 90(10), 1905-1911, 2004#http://www.ncbi.nlm.nih.gov/pubmed/15138470

Rotman N, Pezet D, Fagniez PL, Cherqui D, Celicout B, Lointier P, et al. Adenocarcinoma of the duodenum: factors influencing survival. French Association for Surgical Research. British Journal of Surgery 81(1), 83-85, 1994.#http://www.ncbi.nlm.nih.gov/pubmed/7508805

Salas S, Deville JL, Giorgi R, Pignon T, Bagarry D, Barrau K, et al. Nutritional factors as predictors of response to radio-chemotherapy and survival in unresectable squamous head and neck carcinoma. Radiotherapy & Oncology 87(2), 195-200, 2008.#http://www.ncbi.nlm.nih.gov/pubmed/18342966

Sanchez-Bueno F, Garcia-Marcilla JA, Perez-Flores D, Perez-Abad JM, Vicente R, Aranda F, et al. Prognostic factors in a series of 297 patients with gastric adenocarcinoma undergoing surgical resection. British Journal of Surgery 85(2), 255-260, 1998.#http://www.ncbi.nlm.nih.gov/pubmed/9501830

Schea RA, Perkins P, Allen PK, Komaki R, Cox JD, Schea RA, et al. Limited-stage small-cell lung cancer: patient survival after combined chemotherapy and radiation therapy with and without treatment protocols. Radiology 197(3), 859-862, 1995.#http://www.ncbi.nlm.nih.gov/pubmed/7480770

Sculier JP, Paesmans M, Libert P, Bureau G, Dabouis G, Thiriaux J, et al. Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer. European Lung Cancer Working Party. European Journal of Cancer 30A(9), 1342-1347, 1994.#http://www.ncbi.nlm.nih.gov/pubmed/7999423

Socinski MA, Zhang C, Herndon JE 2nd, Dillman RO, Clamon G, Vokes E, Akerley W, Crawford J, Perry MC, Seagren SL, Green MR. Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity. Ann Oncol. 2004 Jul;15(7):1033-41.#http://www.ncbi.nlm.nih.gov/pubmed/15205196

Songur N, Kuru B, Kalkan F, Ozdilekcan C, Cakmak H, Hizel N, et al. Serum interleukin-6 levels correlate with malnutrition and survival in patients with advanced non-small cell lung cancer. Tumori 90(2), 196-200, 2004.#http://www.ncbi.nlm.nih.gov/pubmed/15237582

Stahl M, Wilke H, Stuschke M, Walz MK, Fink U, Molls M, et al. Clinical response to induction chemotherapy predicts local control and long-term survival in multimodal treatment of patients with locally advanced esophageal cancer. Journal of Cancer Research & Clinical Oncology 131(1), 67-72, 2005.#http://www.ncbi.nlm.nih.gov/pubmed/15480782

Stapley S, Peters TJ, Sharp D, Hamilton W. The mortality of colorectal cancer in relation to the initial symptom at presentation to primary care and to the duration of symptoms: A cohort study using medical records. British Journal of Cancer 95(10), 1321-1325, 2006.#http://www.ncbi.nlm.nih.gov/pubmed/17060933

Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Lung carcinoma symptoms--an independent predictor of survival and an important mediator of African-American disparity in survival. Cancer.2004;101(7):1655-63.#http://www.ncbi.nlm.nih.gov/pubmed/15378496

Tamura M, Ueoka H, Kiura K, Tabata M, Shibayama T, Miyatake K, Gemba K, Hiraki S, Harada M. Prognostic factors of small-cell lung cancer in Okayama Lung Cancer Study Group Trials. Acta Med Okayama. 1998;52(2):105-11. Acta Med Okayama. 1998 Apr;52(2):105-11.;#http://www.ncbi.nlm.nih.gov/pubmed/9588226

Tas F, Aydiner A, Topuz E, Camlica H, Saip P, Eralp Y, et al. Factors influencing the distribution of metastases and survival in extensive disease small cell lung cancer. Acta Oncologica 38(8), 1011-1015, 1999.#http://www.ncbi.nlm.nih.gov/pubmed/10665754

Tavernier E, Le QH, Elhamri M, Thomas X, Tavernier E, Le QH, et al. Salvage therapy in refractory acute myeloid leukemia: prediction of outcome based on analysis of prognostic factors.Leukemia Research 27(3), 205-214, 2003.#http://www.ncbi.nlm.nih.gov/pubmed/12537972

Terwee CB, Nieveen Van Dijkum EJ, Gouma DJ, Bakkevold KE, Klinkenbijl JH, Wade TP, van Wagensveld BA, Wong A, van der Meulen JH. Pooling of prognostic studies in cancer of the pancreatic head and periampullary region: the Triple-P study. Triple-P study group. Eur J Surg. 2000 Sep;166(9):706-12.#http://www.ncbi.nlm.nih.gov/pubmed/11034467

Tian J, Chen ZC, Hang LF, Tian J, Chen Zc, Hang Lf. The effects of nutrition status of patients with digestive system cancers on prognosis of the disease. Cancer Nursing 31(6), 462-467, 2008.#http://www.ncbi.nlm.nih.gov/pubmed/18987513

Tomassetti P, Campana D, Piscitelli L, Casadei R, Nori F, Brocchi E, et al. Endocrine tumors of the ileum: factors correlated with survival. Neuroendocrinology 83(5-6), 380-386, 2006.#http://www.ncbi.nlm.nih.gov/pubmed/17016032

Tonouchi H, Ohmori Y, Tanaka K, Mohri Y, Kobayashi M, Kusunoki M, et al. Postoperative weight loss during hospital stays in patients with gastric cancer undergoing surgical resection. HepatoGastroenterology 55(82-83), 803-806, 2008.;#http://www.ncbi.nlm.nih.gov/pubmed/18613459

Trigui BB, Barrier A, Flahault A, Huguier M. Prognostic factors in advanced pancreatic carcinoma.Multivariate analysis and predictive survival score. Annales de Chirurgie 125(7), 625-630, 2000.#http://www.ncbi.nlm.nih.gov/pubmed/11051691

Werner-Wasik M, Scott C, Graham ML, Smith C, Byhardt RW, Roach M, III, et al. Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 RTOG patients.International Journal of Radiation Oncology, Biology, Physics 44(2), 327-331, 1999.;#http://www.ncbi.nlm.nih.gov/pubmed/10760427

Yu W, Seo BY, Chung HY. Postoperative body-weight loss and survival after curative resection for gastric cancer. Br J Surg. 2002 Apr;89(4):467-70.#http://www.ncbi.nlm.nih.gov/pubmed/11952589#http://www.ncbi.nlm.nih.gov/pubmed/11952589

Yueh B, Feinstein AR, Weaver EM, Sasaki CT, Concato J. Prognostic staging system for recurrent, persistent, and second primary cancers of the oral cavity and oropharynx. Archives of Otolaryngology --Head & Neck Surgery 124(9), 975-981, 1998.#http://www.ncbi.nlm.nih.gov/pubmed/9738805